ConductScience.org, home

Paper40420175

Chemical profiling and anticancer activity of Alnus incana dichloromethane fraction on HeLa cells via cell cycle arrest and apoptosis.

Hesham W and 3 others. BMC Complement Med Ther, 2025. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Chemical profiling and anticancer activity of Alnus incana dichloromethane fraction on HeLa cells via cell cycle arrest and apoptosis. Papers, record 40420175. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40420175

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chemical profiling and anticancer activity of Alnus incana dichloromethane fraction on HeLa cells via cell cycle arrest and apoptosis.
PubMed
Journal
BMC Complement Med Ther
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2025-05-30
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hesham WWalaa
2Elzayat EMEmad M
3Hosney MMohamed
4Abo-Elghiet FFatma

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ApoptosisMajor topic
Cell Cycle CheckpointsMajor topic
Plant ExtractsMajor topic
AlnusMajor topic
Antineoplastic Agents, PhytogenicMajor topic
Humans
HeLa Cells
Methylene Chloride
Uterine Cervical Neoplasms
Cell Line, Tumor
Plant Leaves
Female

Source PubMed

Download CSV of topics

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111843726Analysis of cell-cycle checkpoint pathways in head and neck cancer cell lines: implications for therapeutic strategies.Arch Otolaryngol Head Neck Surg2002https://conductscience.org/library/papers/11843726PubMed
238572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
334508254Cell cycle control in cancer.Nat Rev Mol Cell Biol2022https://conductscience.org/library/papers/34508254PubMed
432492512Induction of programmed necrosis: A novel anti-cancer strategy for natural compounds.Pharmacol Ther2020https://conductscience.org/library/papers/32492512PubMed
529908495Phytol shows anti-angiogenic activity and induces apoptosis in A549 cells by depolarizing the mitochondrial membrane potential.Biomed Pharmacother2018https://conductscience.org/library/papers/29908495PubMed
611511312The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis.J Invest Dermatol2001https://conductscience.org/library/papers/11511312PubMed
729749309The Application of Natural Products in Cancer Therapy by Targeting Apoptosis Pathways.Curr Drug Metab2018https://conductscience.org/library/papers/29749309PubMed
835494086Editorial: Molecular Targets and Therapeutic Strategies in Gynecological Cancers.Front Oncol2022https://conductscience.org/library/papers/35494086PubMed
935667581LC/MS analysis of Viscum cruciatum Sieber ex Boiss. extract with anti-proliferative activity against MCF-7 cell line via G0/G1 cell cycle arrest: An in-silico and in-vitro study.J Ethnopharmacol2022https://conductscience.org/library/papers/35667581PubMed
1035460940Cervical cancer therapies: Current challenges and future perspectives.Tumour Virus Res2022https://conductscience.org/library/papers/35460940PubMed
1135566090α-Linolenic Acid Suppresses Proliferation and Invasion in Osteosarcoma Cells via Inhibiting Fatty Acid Synthase.Molecules2022https://conductscience.org/library/papers/35566090PubMed
1225058905Cisplatin in cancer therapy: molecular mechanisms of action.Eur J Pharmacol2014https://conductscience.org/library/papers/25058905PubMed
1330425336mTOR signalling and cellular metabolism are mutual determinants in cancer.Nat Rev Cancer2018https://conductscience.org/library/papers/30425336PubMed
1437169909The effect of Alnus incana (L.) Moench extracts in ameliorating iron overload-induced hepatotoxicity in male albino rats.Sci Rep2023https://conductscience.org/library/papers/37169909PubMed
1521516412Cell sensitivity assays: the MTT assay.Methods Mol Biol2011https://conductscience.org/library/papers/21516412PubMed
168620501Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio.Cancer Res1996https://conductscience.org/library/papers/8620501PubMed
1712440809Molecular mechanisms of apoptosis and chemosensitivity to platinum and paclitaxel in ovarian cancer: biological data and clinical implications.Eur J Gynaecol Oncol2002https://conductscience.org/library/papers/12440809PubMed
1834494317Anticancer effects of root and beet leaf extracts (Beta vulgaris L.) in cervical cancer cells (HeLa).Phytother Res2021https://conductscience.org/library/papers/34494317PubMed
1939796679Dose-Limiting Toxicities of Paclitaxel in Breast Cancer Patients: Studying Interactions Between Pharmacokinetics, Physical Activity, and Body Composition-A Protocol for an Observational Cohort Study.Cancers (Basel)2024https://conductscience.org/library/papers/39796679PubMed
2036034846Cancer and apoptosis: The apoptotic activity of plant and marine natural products and their potential as targeted cancer therapeutics.Front Pharmacol2022https://conductscience.org/library/papers/36034846PubMed

See all 24 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
41976229Phytochemical Profiles and Antimicrobial Activity of Alnus glutinosa (L.) Gaertn. Leaves Growing in Kazakhstan.Molecules2026https://conductscience.org/library/papers/41976229PubMed
41790249In vitro antiproliferative activity on A549 and HT-29 cell lines and fatty acid profiling of Agaricus bresadolanus and A. hortensis.Naturwissenschaften2026https://conductscience.org/library/papers/41790249PubMed
41754969Nanoencapsulation of Tomentosin-Rich Pulicaria crispa Fraction in MIL-53(Fe) Improves the Release Profile and In Vitro Anti-Colorectal Cancer Activity.Pharmaceutics2026https://conductscience.org/library/papers/41754969PubMed
41673052Cubosomal nanoparticles of lycopene as a novel platform for enhancement in antioxidant and anticancer properties with a molecular docking study.Sci Rep2026https://conductscience.org/library/papers/41673052PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BAX581PubTator's text mininghttps://conductscience.org/library/genes/581NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40420175

GET https://conductscience.org/api/papers/v1/40420175/references?page=2